OpenAI's Sol safety review process remains unclear

Experts including a Georgetown CSET analyst and Databricks co-founder say the government's frontier model safety review process is opaque. An executive order laid out a roadmap but specifics remain unclear, with a former White House advisor stating 'there will not be an FDA for AI.'